Physician profile
Daniel Choi
NPI 1063709848
$8,870.06
in general payments reported to CMS, 2019-2025
12 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,639 · 2020: $744 · 2021: $1,959 · 2022: $296 · 2023: $1,589 · 2024: $496 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,396 · Travel and Lodging: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,396.04 |
| Travel and Lodging | $835.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $6,059.97 | 2019-2025 | |
| Salvin Dental Specialties, INC. | $1,876.90 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $290.95 | 2019-2021 | |
| Zimvie INC. | $151.99 | 2022-2023 | |
| Dentsply Sirona INC | $139.24 | 2021-2025 | Waveone Gold Conform Fit, Vortex Blue Conform Fit |
| Philips North America LLC | $118.55 | 2019-2023 | |
| Septodont INC. | $100.82 | 2022 | |
| Biohorizons Implant Systems INC. | $39.64 | 2025 | Biohorizons Dental Implants |
| Pacira Pharmaceuticals Incorporated | $34.57 | 2024 | Exparel |
| Nobel Biocare USA | $27.31 | 2020 | |
| Orapharma, A Division of Bausch Health US, LLC | $17.68 | 2021 | |
| Colgate Oral Pharmaceuticals, INC. | $12.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.